NCT03159676 2026-02-25
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
Completed
Clinical Trials
22 trialsNCT03007732 2025-12-05
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
University of California, San Francisco
Phase 2 Completed
NCT02170181 2025-09-17
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
Completed
NCT05655715 2024-10-16
CheckPRO
Herlev and Gentofte Hospital
Phase 2 Completed
NCT01985828 2024-10-03
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Wake Forest University Health Sciences
Phase NA Completed
NCT02163317 2024-05-10
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT00977860 2024-05-02
Hypofractionated SBRT For Prostate Cancer
University of Pittsburgh
Phase NA Completed
NCT00643617 2023-05-09
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Accuray Incorporated
Phase NA Completed
NCT00643994 2023-05-09
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Accuray Incorporated
Phase NA Completed
NCT02572284 2023-01-19
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT01856855 2023-01-12
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
University of Alabama at Birmingham
Phase NA Completed
NCT00547339 2022-12-07
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT02680587 2022-11-29
ORIOLE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00377156 2022-09-16
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01859221 2022-09-14
Radiotherapy for Oligometastatic Prostate Cancer
University of Florida
Phase NA Completed
NCT02206334 2022-05-25
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer
NRG Oncology
Phase 1 Completed
NCT02653248 2022-02-09
SBRT for Organ Confined Prostate Cancer
Northwell Health
Phase 1 Completed
NCT00941915 2022-01-24
SMART
Duke University
Phase NA Completed
NCT02192788 2021-11-19
Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer
Grupo de Investigación Clínica en Oncología Radioterapia
Phase NA Completed
NCT01352598 2020-09-23
Stereotactic Body Radiotherapy for Prostate Cancer
Mercy Research
Phase NA Completed
NCT02946008 2019-11-27
Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer
University of Michigan Rogel Cancer Center
Phase 1 Completed
NCT00587964 2016-02-22
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases
Memorial Sloan Kettering Cancer Center
Phase 2 Completed